Back to Search
VIJAY VENKATESAN, MD
MD
Family Medicine Physician
NPI: 1376003632IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
2024016491(MO)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.
PMID 19470936·J Clin Oncol·2009
2-rct
Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer.
PMID 17579613·Prostate Cancer Prostatic Dis·2008
4-observational
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
PMID 18413638·J Clin Oncol·2008
3-trial
Microvascular changes in radiation-induced oral mucositis.
PMID 19128685·J Otolaryngol Head Neck Surg·2008
8-other
Immuolocalization of nestin in pancreatic tissue of mice at different ages.
PMID 19084919·World J Gastroenterol·2008
7-preclinical
A prospective evaluation of helical tomotherapy.
PMID 17321068·Int J Radiat Oncol Biol Phys·2007
3-trial
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202.
PMID 17689883·Int J Radiat Oncol Biol Phys·2007
3-trial
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
PMID 17960013·N Engl J Med·2007
3-trial
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
PMID 17881290·Lancet Oncol·2007
3-trial
Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02.
PMID 17575222·Clin Cancer Res·2007
3-trial
Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR.
PMID 17336224·Int J Radiat Oncol Biol Phys·2007
2-rct
South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
PMID 16437189·J Hum Genet·2006
8-other
Pelvic chemoradiotherapy after chemotherapy for metastatic bladder cancer.
PMID 16672111·Can J Urol·2006
8-other
Infrared and ab initio studies on 1,2,4,5-tetrafluorobenzene clusters with methanol and 2,2,2-trifluoroethanol: presence and absence of an aromatic C-H...O hydrogen bond.
PMID 16838964·J Phys Chem A·2005
8-other
TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
PMID 16029783·Int J Radiat Oncol Biol Phys·2005
8-other
Computed tomographic volumetric analysis as a predictor of local control in laryngeal cancers treated with conventional radiotherapy.
PMID 15931812·J Otolaryngol·2004
8-other
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.
PMID 15169799·J Clin Oncol·2004
8-other
Matrix isolation infrared and ab initio study of the conformations of 2,2-dimethoxypropane.
PMID 12714073·Spectrochim Acta A Mol Biomol Spectrosc·2003
4-observational
Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up.
PMID 14630257·Int J Radiat Oncol Biol Phys·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7900 LEES SUMMIT RD
KANSAS CITY, MO 64139 - Phone
- (816) 404-7600
Quick Facts
- NPI
- 1376003632
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile